Evidence map›Paper›PMID 27864819›Full record

ReviewNanoscale research letters2016

Can We Optimize Arc Discharge and Laser Ablation for Well-Controlled Carbon Nanotube Synthesis?

Rasel Das, Zohreh Shahnavaz, Md Eaqub Ali, Mohammed Moinul Islam, Sharifah Bee Abd Hamid

Abstract readReview
In one paragraph

Review in Nanoscale research letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Chemical Vapour Deposition of MWCNT on Silica Coated FeInternational journal of analytical chemistry · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rasel DasNanotechnology and Catalysis Research Center, University of Malaya, 50603, Kuala Lumpur, Malaysia. raselgeneticist@gmail.com.
Zohreh ShahnavazNanotechnology and Catalysis Research Center, University of Malaya, 50603, Kuala Lumpur, Malaysia.
Md Eaqub AliNanotechnology and Catalysis Research Center, University of Malaya, 50603, Kuala Lumpur, Malaysia.
Mohammed Moinul IslamDepartment of Biochemistry and Molecular Biology, University of Chittagong, 4331, Hathazari, Bangladesh.
Sharifah Bee Abd HamidNanotechnology and Catalysis Research Center, University of Malaya, 50603, Kuala Lumpur, Malaysia. sharifahbee@um.edu.my.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although many methods have been documented for carbon nanotube (CNT) synthesis, still, we notice many arguments, criticisms, and appeals for its optimization and process control. Industrial grade CNT production is urgent such that invention of novel methods and engineering principles for large-scale synthesis are needed. Here, we comprehensively review arc discharge (AD) and laser ablation (LA) methods with highlighted features for CNT production. We also display the growth mechanisms of CNT with reasonable grassroots knowledge to make the synthesis more efficient. We postulate the latest developments in engineering carbon feedstock, catalysts, and temperature cum other minor reaction parameters to optimize the CNT yield with desired diameter and chirality. The rate limiting steps of AD and LA are highlighted because of their direct role in tuning the growth process. Future roadmap towards the exploration of CNT synthesis methods is also outlined.

Indexed as

Arc dischargeCarbon nanotube synthesisLaser ablationOptimizationProcess control

Identifiers

PMID27864819
PMCPMC5116021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.